Clinical Trial Update: Oropharynx (OPX) Biomarker Trial

View source ↗

Summary

Mayo Clinic is conducting a biomarker-focused clinical trial in patients with HPV-positive and HPV-negative oropharyngeal cancer across stage III to IV, and the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma
• Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Mayo Clinic | Conditions: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Status: RECRUITING